In a mouse model designed to conditionally knockdown TGFBR2 in the proximal colon, TGFBR2 impairment in combination with Wnt-β-catenin pathway activation promoted the upregulation of Gasdermin C, which stimulated the proliferation of CRC cells [48]. The gene discussed is TGFBR2; the disease is colorectal carcinoma.